ZOLINZA® (vorinostat): Prescription Information and Other Resources for Patients

If you can read this, then your browser cannot interpret Javascript. To take full advantage of what this Web site has to offer, please make sure that you have Javascript enabled in your browser preferences, or update to a browser that supports Javascript. Thank you.

Cutaneous t-cell lymphoma treatment. Learn how to provide
ctcl support.

Learn more about the steps you can take to care for yourself
while you care for your loved one.

Learning About ZOLINZA® (vorinostat) CTCL treatment Understanding CTCL Care-Partner corner Talking with your treatment team Resources Patient Information Physician Prescribing Information Information for health care professionals

To report side effects, call 800-FDA-1088.

Site map

What is ZOLINZA?

CTCL treatment

Understanding CTCL

Care-Partner corner

Talking with your treatment team

Patient Information

Physician Prescribing Information

ZOLINZA is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
This site is intended for residents of the United States, its territories, and Puerto Rico.
20850619(7)-01/10-ZOL